igf-1 lr3 muscle growth effects Therapy Improves Size and Function in Experimental Peripheral Arterial Disease IGF-1: Miracle Hormone or Health
Description
Cell 129 , 465472 (2007)
Contributors: Sebastian Padayatty, Arie Katz and Mark Levine wrote the first draft, Hugh Riordan contributed to data acquisition, Stephen Hewitt conducted pathology reviews and John Hoffer revised this article
hazard ratio, HR = 1.86) or other KRAS mutations (HR = 1.15) (Fig
Thus, two main conclusions can be drawn: first, the degree of receptor phosphorylation is not necessarily directly proportional to the strength of desensitization (Alcntara-Hernndez et al., 2017)
